Exp Clin Endocrinol Diabetes 2020; 128(08): 528-539
DOI: 10.1055/a-0754-5622
Article

Combined Effects of Single Nucleotide Polymorphisms (SNPs) within C-reactive Protein (CRP) and Environmental Parameters on Risk and Prognosis for Diabetic Foot Osteomyelitis Patients

Shanjin Wang
1   Department of Spinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
,
Haowei Xu
1   Department of Spinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
,
Ningfeng Zhou
1   Department of Spinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
,
Weidong Zhao
1   Department of Spinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
,
Desheng Wu
1   Department of Spinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
,
Bin Shen
1   Department of Spinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
› Author Affiliations
Funding: This paper was funded by the National Natural Science Foundation of China (81572181), Program for Young Excellent Talents in Pudong New Area health system (PWRq2016–27), and Key Discipline Construction Project of Pudong Health Bureau of Shanghai (PWZxk2017–08).

Abstract

Purpose This study was aimed to discover the combined effects of single nucleotide polymorphisms (SNPs) within the C-reactive protein (CRP) gene and potential environmental factors on the risk and prognosis for diabetic foot osteomyelitis (DFO).

Methods A total of 1734 diabetes mellitus patients, 681 with DFO and 1053 without DFO, were successfully recruited, as well as 1261 healthy control individuals. Participants data were recorded regarding age, gender, smoking and drinking history, body mass index (BMI), hypertension, cacosmia, and ulceration. A total of 11 SNPs within the CRP gene were designated for exploration, by logistic regression analyses, of how they might interact with environmental factors to affect susceptibility to DFO.

Results Frequencies of smoking and drinking, and incidence of hypertension, cacosmia, or ulceration displayed marked differences (all P<0.05) between DFO and non-DFO patients. Furthermore, allele G of rs11265260 (A>G), allele G of rs1800947 (C>G), and allele T of rs3093059 (T>C) and rs1130864 (C>T) exhibited a trend to increase risk of DFO (all P<0.05). Allele G of rs11265260 (A>G), allele G of rs1800947 (C>G) and rs3093068 (G>C), and allele T of rs1130864 (C>T) were significant predictors of poor prognosis among DFO patients (P<0.05). In addition, genotypes of rs11265260 (i.e., GG and AG), rs1800947 (i.e., CG and GG), rs3093059 (i.e., TT) and rs113084 (i.e., CT and TT) amplified the influence of smoking, alcohol consumption, cacosmia, and ulceration on progression from non-DFO to DFO (all γ>1).

Conclusion Genetic mutations within CRP functioned interactively with external factors to affect DFO risk.

Supplementary Material



Publication History

Received: 07 August 2018
Received: 21 September 2018

Accepted: 05 October 2018

Article published online:
15 June 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Whiting DR, Guariguata L, Weil C. et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-321
  • 2 Frykberg RG, Armstrong DG, Giurini J. et al. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg 2000; 39: S1-S60
  • 3 Lavery LA, Peters EJ, Armstrong DG. et al. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract 2009; 83: 347-352
  • 4 Mutluoglu M, Sivrioglu AK, Eroglu M. et al. The implications of the presence of osteomyelitis on outcomes of infected diabetic foot wounds. Scand J Infect Dis 2013; 45: 497-503
  • 5 Acharya S, Soliman M, Egun A. et al. Conservative management of diabetic foot osteomyelitis. Diabetes Res Clin Pract 2013; 101: e18-e20
  • 6 Henke PK, Blackburn SA, Wainess RW. et al. Osteomyelitis of the foot and toe in adults is a surgical disease: Conservative management worsens lower extremity salvage. Ann Surg 2005; 241: 885-892. discussion 892-884
  • 7 Nelson EA, O'Meara S, Golder S. et al. Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 2006; 23: 348-359
  • 8 Berendt AR, Peters EJ, Bakker K. et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 2008; 24 (Suppl. 01) S145-S161
  • 9 Fleischer AE, Didyk AA, Woods JB. et al. Combined clinical and laboratory testing improves diagnostic accuracy for osteomyelitis in the diabetic foot. J Foot Ankle Surg 2009; 48: 39-46
  • 10 Gewurz H, Zhang XH, Lint TF. Structure and function of the pentraxins. Curr Opin Immunol 1995; 7: 54-64
  • 11 Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108: 1930-1932
  • 12 Emsley J, White HE, O'Hara BP. et al. Structure of pentameric human serum amyloid P component. Nature 1994; 367: 338-345
  • 13 Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999; 42: 23-30
  • 14 Firooz N, Albert DA, Wallace DJ. et al. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 2011; 20: 588-597
  • 15 Hansen TK, Forsblom C, Saraheimo M. et al. Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia 2010; 53: 1517-1524
  • 16 Galarraga B, Khan F, Kumar P. et al. C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 1780-1784
  • 17 Monami M, Vivarelli M, Desideri CM. et al. Pulse pressure and prediction of incident foot ulcers in type 2 diabetes. Diabetes Care 2009; 32: 897-899
  • 18 Monteiro-Soares M, Dinis-Ribeiro M. External validation and optimisation of a model for predicting foot ulcers in patients with diabetes. Diabetologia 2010; 53: 1525-1533
  • 19 Centers for Disease Control and Prevention. History of foot ulcer among persons with diabetes–United States, 2000-2002. MMWR Morb Mortal Wkly Rep 2003; 52: 1098-1102
  • 20 Williams LH, Rutter CM, Katon WJ. et al. Depression and incident diabetic foot ulcers: a prospective cohort study. Am J Med 2010; 123: e743
  • 21 Guerrero-Romero F, Rodriguez-Moran M. Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes. J Diabetes Complications 1998; 12: 193-196
  • 22 Kastenbauer T, Sauseng S, Sokol G. et al. A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc 2001; 91: 343-350
  • 23 Levin ME. Classification of diabetic foot wounds. Diabetes Care 1998; 21: 681
  • 24 Vinayagamoorthy N, Hu HJ, Yim SH. et al. New variants including ARG1 polymorphisms associated with C-reactive protein levels identified by genome-wide association and pathway analysis. PLoS One 2014; 9: e95866
  • 25 Dorajoo R, Li R, Ikram MK. et al. Are C-reactive protein associated genetic variants associated with serum levels and retinal markers of microvascular pathology in Asian populations from Singapore?. PLoS One 2013; 8: e67650
  • 26 Wu Y, McDade TW, Kuzawa CW. et al. Genome-wide association with C-reactive protein levels in CLHNS: Evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. Inflammation 2012; 35: 574-583
  • 27 Okada Y, Takahashi A, Ohmiya H. et al. Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus. Hum Mol Genet 2011; 20: 1224-1231
  • 28 Kim JJ, Yun SW, Yu JJ. et al. Common variants in the CRP promoter are associated with a high C-reactive protein level in kawasaki disease. Pediatr Cardiol 2015; 36: 438-444
  • 29 Reiner AP, Beleza S, Franceschini N. et al. Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women. Am J Hum Genet 2012; 91: 502-512
  • 30 Naitza S, Porcu E, Steri M. et al. A genome-wide association scan on the levels of markers of inflammation in sardinians reveals associations that underpin its complex regulation. PLoS Genet 2012; 8: e1002480
  • 31 Dehghan A, Dupuis J, Barbalic M. et al. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011; 123: 731-738
  • 32 Sabatti C, Service SK, Hartikainen AL. et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009; 41: 35-46
  • 33 Elliott P, Chambers JC, Zhang W. et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009; 302: 37-48
  • 34 Melzer D, Perry JR, Hernandez D. et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 2008; 4: e1000072
  • 35 Reiner AP, Barber MJ, Guan Y. et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 2008; 82: 1193-1201
  • 36 Ridker PM, Pare G, Parker A. et al. Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: The Women's Genome Health Study. Am J Hum Genet 2008; 82: 1185-1192
  • 37 Amos CI, Wu X, Broderick P. et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40: 616-622
  • 38 Benjamin EJ, Dupuis J, Larson MG. et al. Genome-wide association with select biomarker traits in the framingham heart study. BMC Med Genet 2007; 8 (Suppl. 01) S11
  • 39 Kocarnik JM, Pendergrass SA, Carty CL. et al. Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet 2014; 7: 178-188
  • 40 Singh P, Singh M, Nagpal HS. et al. A novel haplotype within C-reactive protein gene influences CRP levels and coronary heart disease risk in Northwest Indians. Mol Biol Rep 2014; 41: 5851-5862
  • 41 Ghaffari MA, Askari Sede S, Rashtchizadeh N. et al. Association of CRP gene polymophism with CRP levels and coronary artery disease in type 2 diabetes in Ahwaz, Southwest of Iran. BioImpacts 2014; 4: 133-139
  • 42 Shen C, Sun X, Wang H. et al. Association study of CRP gene and ischemic stroke in a Chinese Han population. J Mol Neurosci 2013; 49: 559-566
  • 43 Nair AM, Goel R, Hindhumati M. et al. C-reactive protein gene polymorphisms (rs1205) in asian indian patients with takayasu arteritis: Associations and phenotype correlations. Int J Rheum Dis 2018; 21: 732-739
  • 44 Khoury MJ, Wagener DK. Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet 1995; 56: 835-844
  • 45 Ottman R. An epidemiologic approach to gene-environment interaction. Genet Epidemiol 1990; 7: 177-185
  • 46 Taioli E, Zocchetti C, Garte S. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environ Health Perspect 1998; 106: 67-70
  • 47 Khoury MJ, James LM. Population and familial relative risks of disease associated with environmental factors in the presence of gene-environment interaction. Am J Epidemiol 1993; 137: 1241-1250
  • 48 Shostak S. Locating gene-environment interaction: at the intersections of genetics and public health. Soc Sci Med 2003; 56: 2327-2342
  • 49 Richard JL, Sotto A, Lavigne JP. New insights in diabetic foot infection. World J Diabetes 2011; 2: 24-32
  • 50 Lipsky BA, Berendt AR, Cornia PB. et al. Executive summary: 2012 Infectious diseases Society of America Clinical Practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54: 1679-1684
  • 51 Smith IM, Austin OM, Batchelor AG. The treatment of chronic osteomyelitis: a 10 year audit. J Plast Reconstr Aesthet Surg 2006; 59: 11-15
  • 52 Game FL, Jeffcoate WJ. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 2008; 51: 962-967
  • 53 Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930; 52: 561-571
  • 54 Wood HF, Mc CM, Slater RJ. The occurrence during acute infections of a protein not normally present in the blood. V. Physical-chemical properties of the C-reactive protein crystallized by a modified technique. J Exp Med 1954; 100: 71-79
  • 55 Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168
  • 56 Motie M, Brockmeier S, Potempa LA. Binding of model soluble immune complexes to modified C-reactive protein. J Immunol 1996; 156: 4435-4441
  • 57 Heuertz RM, Schneider GP, Potempa LA. et al. Native and modified C-reactive protein bind different receptors on human neutrophils. Int J Biochem Cell Biol 2005; 37: 320-335
  • 58 Griselli M, Herbert J, Hutchinson WL. et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999; 190: 1733-1740
  • 59 Rizzello V, Liuzzo G, Giannuario GD. et al. 1059G/C polymorphism within the exon 2 of the C-reactive protein gene: relationship to C-reactive protein levels and prognosis in unstable angina. Coron Artery Dis 2007; 18: 533-538
  • 60 Lange LA, Carlson CS, Hindorff LA. et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006; 296: 2703-2711
  • 61 Kovacs A, Green F, Hansson LO. et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 2005; 178: 193-198
  • 62 Kardys I, de Maat MP, Uitterlinden AG. et al. C-reactive protein gene haplotypes and risk of coronary heart disease: the rotterdam study. Eur Heart J 2006; 27: 1331-1337
  • 63 Russell AI, Cunninghame Graham DS, Shepherd C. et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004; 13: 137-147
  • 64 Edberg JC, Wu J, Langefeld CD. et al. Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 2008; 17: 1147-1155
  • 65 Rhodes B, Merriman ME, Harrison A. et al. A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med 2010; 7: e1000341
  • 66 Morita A, Nakayama T, Soma M. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens 2006; 19: 593-600
  • 67 Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 2009; 49: 1541-1549